Myocardial damage associated with elective percutaneous coronary intervention in Chinese patients: a retrospective study

机译：选择性经皮冠状动脉介入治疗对中国患者的心肌损害：一项回顾性研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

To determine the prevalence of percutaneous coronary intervention (PCI) related myocardial damage (injury or myocardial infarction), investigate several cardiac biomarkers, explore possible risk factors and assess survival in patients undergoing elective PCI.

机译：为了确定经皮冠状动脉介入治疗（PCI）相关的心肌损伤（损伤或心肌梗塞）的患病率，研究几种心脏生物标志物，探讨可能的危险因素并评估接受择期PCI的患者的生存率。

著录项

期刊名称 The Journal of International Medical Research
作者
Shengjia Sun; Yang Ou; Haiming Shi; Jianfeng Luo; Xinping Luo; Yunzhi Shen; Yufei Chen; Xiaojin Liu; Zhidong Zhu; Wei Shen;
展开▼
作者单位

展开▼
年(卷),期 2020(48),3
年度 2020
页码 -1
总页数 12
原文格式 PDF
正文语种
中图分类药学;医学史;
关键词
Percutaneous coronary intervention; biomarkers; myocardial infarction; coronary artery disease; risk factors; prognosis;

机译：经皮冠状动脉介入治疗;生物标志物;心肌梗死;冠状动脉疾病;危险因素;预后;

相似文献

外文文献
中文文献
专利

1. Myocardial damage associated with elective percutaneous coronary intervention in Chinese patients: a retrospective study [J] . Shengjia Sun, Yang Ou, Haiming Shi, Journal of International Medical Research . 2020,第3期

机译：与选修冠状动脉介入的心肌损伤有关的中国患者：回顾性研究
2. The periprocedural myocardial damage prevention during elective percutaneous coronary intervention as a result of pharmacological preconditioning with an oral form of nicorandil in patients with stable coronary artery disease. Pilot study [J] . Gostishchev R. V, Soboleva G. N., Samko A. N., Терапевтичесκий архив . 2018,第9期

机译：稳定冠状动脉疾病患者口服芽孢杆菌的药理学预处理期间选修经皮冠状动脉干预期间的霸主经心肌损伤预防。试验研究
3. A therapeutic window for platelet reactivity for patients undergoing elective percutaneous coronary intervention: Results of the ARMYDA-PROVE (Antiplatelet therapy for Reduction of MYocardial Damage during AngioplastyPlatelet Reactivity for Outcome Validation Effort) Study [J] . MangiacapraF., PattiG., BarbatoE., JACC. Cardiovascular interventions . 2012,第3期

机译：进行选择性经皮冠状动脉介入治疗的患者的血小板反应性的治疗窗口：ARMYDA-PROVE（抗血小板疗法可减少血管成形术中的心肌损伤血小板反应性以验证结果的努力）研究
4. Impact of Renal Insufficiency on 30-Day Outcomes in Patients with ST-Segment Elevation Myocardial Infarction Treated with Primary Percutaneous Coronary Intervention [C] . Sakai K., Tosaka A., Soga Y., World Congress on Heart Disease. . 2013

机译：肾功能不全对初级经皮冠状动脉干预治疗的ST段升高心肌梗死患者30天后的影响
5. Meta-analysis: The impact of thrombectomy during PCI (percutaneous coronary intervention) on mortality, re-infarction and target vessel revascularization among patients with ST elevation myocardial infarction compared with standard PCI. [D] . Martar, Martar. 2016

机译：荟萃分析：与标准PCI相比，ST抬高型心肌梗死患者在PCI（经皮冠状动脉介入治疗）期间进行血栓切除术对死亡率，再梗塞和靶血管血运重建的影响。
6. Relationship Between Preoperative Low-Density Lipoprotein Cholesterol and Periprocedural Myocardial Injury in Patients Following Elective Percutaneous Coronary Intervention in Southern China [O] . Zhixiong Zhong, Jing Liu, Qifeng Zhang, 1923

机译：华南择期经皮冠状动脉介入治疗患者术前低密度脂蛋白胆固醇与围手术期心肌损伤的关系
7. β-blocker use before elective percutaneous coronary intervention as a risk factor for periprocedural myocardial injury incidence in male patients below 75 years old: a single-center retrospective study [O] . Min Wang, Qingbo Lv, Yao Wang, 2021

机译：β-resserer在选修经皮冠状动脉干预之前使用作为75岁以下男性患者群体心肌损伤发病率的危险因素：单中心回顾性研究

Myocardial damage associated with elective percutaneous coronary intervention in Chinese patients: a retrospective study

摘要

著录项

相似文献

相关主题

期刊订阅